Dental and Medical Problems

Dent Med Probl
JCR Impact Factor (IF) – 2.6
Scopus CiteScore (2022) – 2.9 (CiteScore Tracker 2023 – 4.0)
Index Copernicus (ICV 2022) – 134.48
MNiSW – 70 pts
Average rejection rate (2023) – 82.91%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – bimonthly


 

Download original text (EN)

Dental and Medical Problems

2016, vol. 53, nr 3, July-September, p. 401–407

doi: 10.17219/dmp/63401

Publication type: review

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Nutritional Problems in Head and Neck Cancer Patients

Problemy żywieniowe chorych na nowotwory głowy i szyi

Marta Gara-Rucińska1,B,C,D, Anna Paulina Lehmann-Kalata2,B,C,D, Lidia Łysenko3,A,E,F

1 Department of Maxillofacial Surgery, Wroclaw Medical University, Wrocław, Poland

2 Department of Conservative Dentistry and Periodontology, Poznan University of Medical Sciences, Poznań, Poland

3 2nd Department of Anesthesiology and Intensive Care, Wroclaw Medical University, Wrocław, Poland

Abstract

Head and neck tumors are the fifth most common type of cancer and at the same time the fifth most common cause of death associated with cancer in the world. The location of a tumor in the head and neck have a negative effect on the willingness and the ability to intake food. Frequently observed, malnutrition results in an unfavorable impact on the course of cancer and reduces the effectiveness of the therapy. Nutritional status disorders result in prolonged hospitalization, increased costs of treatment, worsening of the prognosis and reduced quality of life of patients. In addition to cancer treatment, it is necessary to assess the nutritional status of the patient, as well as the risk of malnutrition. In order to increase the tolerance of the patient to treatment, reduce the incidence of complications and duration of hospital stay, it is always advisable to consider nutritional therapy parallel to cancer treatment. Dietary intervention, which consists of dietary counseling, the use of oral industrial diets, enteral or parenteral nutrition, should always be adapted to the clinical situation. For these reasons, the European Society for Clinical Nutrition and Metabolism (ESPEN) have, for several years now, appointed teams of experts entrusted with the development of guidelines on the most important aspects of nutritional therapy. In Poland, despite many efforts of the Polish Association of Parenteral and Enteral Nutrition, awareness of the importance of nutritional status and nutrition in the treatment of patients is still minimal.

Key words

nutrition, nutritional therapy, cancer of the head and neck

Słowa kluczowe

żywienie, terapia żywieniowa, nowotwory głowy i szyi

References (35)

  1. Kawecki A., Nawrocki S.: Malignant head and neck neoplasms – diagnostic-therapeutic management guidelines for malingnant neoplasms. Gdańsk, Viamedica 2013, 4–5 [in Polish].
  2. Szymczak A., Niśkiewicz I., Krela-Kaźmierczak I., Linke K.: Influence of alcohol on selected gastrointestinal disorders. Now. Lek. 2009, 78, 222–227 [in Polish].
  3. Więcławska M., Kukwa A., Malejczyk M., Majewski S., Borowicz K.: Human Papillomavirus (HPV) infections in the oral cavity and the throat. Czas. Stomatol. 2005, 58, 689–702 [in Polish].
  4. Bocian J., Januszkiewicz-Lewandowska D.: Epstein-Barr virus infection – life cycle, methods of diagnosis, associated diseases. Post. Hig. Med. Dosw. 2011, 65, 286–298 [in Polish].
  5. Löser C., Aschl G., Hébuterne X., Mathus-Vliegen E.M.H., Muscaritoli M., Niv Y., Rollins H., Singer P., Skelly R.: Guidelines on enteral nutrition. Clin. Nutr. 2006, 25, 245–259.
  6. Karczmarek-Borowska B., Hoczela I.: Nutritional treatment in neoplastic diseases. Prz. Med. Uniw. Rzesz. 2010, 2, 221–226 [in Polish].
  7. Kłęk S.: Nutritional treatment in oncology. Onkol. Prakt. Klin. 2011, 7, 269–273 [in Polish].
  8. Bozzetti F.: Nutritional support of the oncology patient. Clin. Rev. Oncol. Hematol. 2013, 87, 172–200.
  9. Ferreira C., Camilo M., Pena R., Ravasco P.: Undernutrition and nutritional supplements in oncology: What do health professionals and caregivers know? – A pilot survey. e-SPEN J. 2012, 7, 46–49.
  10. Swora E., Derc K., Grzymisławski M., Golusiński W.: Nutrition in patients with head and neck tumours. Gastroenterol. Pol. 2009, 16, 69–76.
  11. Król K., Jastrzębski T., Jaśkiewicz J.: The analysis of the emotional state of patients with malignancy qualified for surgical treatment. J. Oncol. 2011, 61, 40 [in Polish].
  12. Jack D., Dawson F., Reilly J., Shoaib T.: Guideline for prophylactic feeding tube insertion in patients undergoing resection of head and neck cancers. J. Plast. Reconstr. Aesthet. Surg. 2012, 65, 610–615.
  13. Marin Caro M., Laviano A., Pichard C.: Nutritional intervention and quality of life in adult oncology patients. Clin. Nutr. 2007, 26, 289–301.
  14. Kłęk S., Jarosz J., Jassen J., Kapała A., Krawczyk J., Krzakowski M., Misiak M., Szczepanek K.: Polish recommendations on enteral and parenteral nutrition in oncology — part two: Enteral nutrition. Onkol. Prakt. Klin. 2013, 9, 209–216 [in Polish].
  15. Kłęk S., Jankowski M., Kruszewski W., Fijuth J., Kapała A., Kabata P., Wysocki P., Krzakowski M., Rutkowski P.: Nutritional treatment standards in oncology. J. Oncol. 2015, 65, 320–337 [in Polish].
  16. Nishiwaki S., Iwashita M., Goto N., Hayashi M., Takada J., Asano T., Tagami A., Hatakeyama H., Hayashi T., Maeda T., Saito K.: Predominant copper deficiency during prolonged enteral nutrition through a jejunostomy tube compared to that through a gastrostomy tube. Clin. Nutr. 2011, 30, 585–589.
  17. Kohn M., Golden N., Shenker R.: Cardiac arrest and delirium: Presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. J. Adolesc. Health. 1998, 22, 239–243.
  18. Mehanna H., Moledina J., Travis J.: Refeeding syndrome: What it is, and how to prevent and treat it. BMJ, 2008, 336, 7659, 1495–1498.
  19. De Sa J.S., Moreira D.C., Louvera Silva K.A., Morgano M.A., Quintaes K.D.: Consumption of oral hospital diets and percent adequacy of minerals in oncology patients as an indicative for the use of oral supplements. Clin. Nutr. 2014, 33, 655–661.
  20. Osuch-Wójcikiewicz E., Bruzgielewicz A.: Complications after radiotherapy of head and neck malignancies. Otolaryngol. 2010, 9, 1–6 [in Polish].
  21. Milecki P.: Selected aspects of adverse effects of head and neck radiation therapy. Post. Chir. Głowy Szyi 2004, 1, 15–32 [in Polish].
  22. Hancock P., Epstein J., Sadler G.: Oral and dental management related to radiation therapy for head and neck cancer. J. Dent. Assoc. 2003, 69, 585–590.
  23. Chang H., Sheen L., Lei Y.: The protective role of carotenoids and polyphenols in patients with head and neck cancer. Review Article. J. Chin. Med. Assoc. 2015, 78, 89–95.
  24. Dudziak K., Regulska-Ilow B.: The importance of glycemic load of the diet in the development of cancer. Post. Hig. Med. Dosw. 2013, 67, 449–462.
  25. Abdelwahab M., Fenton K., Preul M., Rho J., Lynch A., Stafford P., Scheck A.: The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PloS One, 2012, 7, 5, e36197.
  26. Fine E., Segal-Isaacson C., Feinman R., Herszkopf S., Romano M., Tomuta N., Bontempo A., Negassa A., Sparano J.: Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients. Nutr. 2012, 28, 1028–1035.
  27. Thorseng T., Witte D.R., Vistisen D., Borch-Johnsen K., Bjerregard P., Jorgensen M.E.: The association betwen n-3 fatty acids in erythrocyte membranes and insulin resistance: The Inuit Health in Transition Study. Int. J. Circumpolar. Health, 2009, 68, 327–336.
  28. Germain E., Chajes V., Cougnault S., Lhuillery C., Bougnoux P.: Enhancement of doxorobicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: Relationship to lipid peroxidation. Int. J. Cancer, 1998, 75, 578–583.
  29. Klapan I., Katic V., Culo F., Sabolovic D., Cuk V., Fumic K., Simovic S.: Lipid bound sialic acid, prostaglandin E and histaminę in head and neck cancer. Europ. J. Cancer, 1993, 29A, 839–845.
  30. Klein S., Simes J., Blackburn G.: Total parenteral nutrition and cancer clinical trials. Cancer, 1986, 58, 1378–1386.
  31. Drissi M., Cwieluch O., Lechner P., Radziwill R., Vehling-Kaiser U., Hengst K., Masin M.: Nutrition care in patients with cancer: A retrospective multicenter analysis of current practice – indications for further studies? Clin. Nutr. 2015, 34, 207–211.
  32. Jagielska B.: Supportive treatment in head and neck cancer. Oncol. Clin. Pract. 2012, 8, 189–196.
  33. La Vecchia C., Tavani A., Franceschi S., Levi F., Corrao G., Negri E.: Epidemiology and prevention of oral cancer. Oral Oncol. 1997, 33, 302–312.
  34. Balch C.M., Gershenwald J.E., Soong S.J.: Final version of 2009 AJCC melanoma staging classification. J. Clin. Oncol. 2009, 27, 6199–6206.
  35. Sobin L.H., Fleming I.D.: TNM classification of malignant tumors. Cancer, 1997, 80, 1803–1804.
© Wroclaw Medical University